Literature DB >> 27156385

Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission.

Yongjun Tian1, Cheng-Fu Kuo1, Omid Akbari1, Jing-Hsiung James Ou2.   

Abstract

In contrast to horizontal transmission of hepatitis B virus (HBV) between adults, which often leads to self-limited acute infection, vertical transmission of HBV from mother to child often leads to chronic infection. However, the mechanisms linking vertical transmission with chronic infection are not known. We developed a mouse model to study the effect of maternal HBV infection on HBV persistence in offspring and found that HBV carried by the mother impaired CD8(+) T cell responses to HBV in her offspring, resulting in HBV persistence. This impairment of CD8(+) T cell responses was mediated by hepatic macrophages, which were predisposed by maternal HBV e antigen (HBeAg) to support HBV persistence by upregulation of inhibitory ligand PD-L1 and altered polarization upon restimulation with HBeAg. Depletion of hepatic macrophages led to CD8(+) T cell activation and HBV clearance in the offspring, raising the possibility of targeting macrophages to treat chronic HBV patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HBV e antigen; HBV vertical transmission; Kupffer cells; PD-1; PD-L1; hepatitis B virus

Mesh:

Substances:

Year:  2016        PMID: 27156385      PMCID: PMC4871724          DOI: 10.1016/j.immuni.2016.04.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  34 in total

1.  Infection of the fetus with hepatitis B e antigen via the placenta.

Authors:  J S Wang; Q R Zhu
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Authors:  Gregor Ebert; Simon Preston; Cody Allison; James Cooney; Jesse G Toe; Michael D Stutz; Samar Ojaimi; Hamish W Scott; Nikola Baschuk; Ueli Nachbur; Joseph Torresi; Ruth Chin; Danielle Colledge; Xin Li; Nadia Warner; Peter Revill; Scott Bowden; John Silke; C Glenn Begley; Marc Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

3.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

Authors:  K Okada; I Kamiyama; M Inomata; M Imai; Y Miyakawa
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

4.  Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

Authors:  W F Carman; M R Jacyna; S Hadziyannis; P Karayiannis; M J McGarvey; A Makris; H C Thomas
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

5.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

6.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

Authors:  D R Milich; J E Jones; J L Hughes; J Price; A K Raney; A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport.

Authors:  C T Yeh; Y F Liaw; J H Ou
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ming-Yang Lai; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Med Virol       Date:  2004-10       Impact factor: 2.327

Review 10.  Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.

Authors:  David Milich; T Jake Liang
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

View more
  60 in total

Review 1.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

2.  Heterologous prime-boost immunization with vesiculovirus-based vectors expressing HBV Core antigen induces CD8+ T cell responses in naïve and persistently infected mice and protects from challenge.

Authors:  Carolina Chiale; Safiehkhatoon Moshkani; John K Rose; Michael D Robek
Journal:  Antiviral Res       Date:  2019-05-30       Impact factor: 5.970

Review 3.  Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

Authors:  Barbara Rehermann; Robert Thimme
Journal:  Gastroenterology       Date:  2018-09-26       Impact factor: 22.682

Review 4.  Mechanisms of Hepatitis B Virus Persistence.

Authors:  Kuen-Nan Tsai; Cheng-Fu Kuo; Jing-Hsiung James Ou
Journal:  Trends Microbiol       Date:  2017-08-16       Impact factor: 17.079

5.  Core gene insertion in hepatitis B virus genotype G functions at both the encoded amino acid sequence and RNA structure levels to stimulate core protein expression.

Authors:  Jing Zhang; Li Zong; Yongxiang Wang; Cheng Li; Chaoyang Chen; Yumei Wen; Jisu Li; Shuping Tong
Journal:  Virology       Date:  2018-11-08       Impact factor: 3.616

Review 6.  Vaccination strategies to enhance immunity in neonates.

Authors:  Tobias R Kollmann; Arnaud Marchant; Sing Sing Way
Journal:  Science       Date:  2020-05-08       Impact factor: 47.728

Review 7.  Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Authors:  Marc G Ghany; Jordan J Feld; Kyong-Mi Chang; Henry L Y Chan; Anna S F Lok; Kumar Visvanathan; Harry L A Janssen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-02-10

Review 8.  Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B.

Authors:  Aleksei Suslov; Stefan Wieland; Stephan Menne
Journal:  Curr Opin Virol       Date:  2018-02-20       Impact factor: 7.090

9.  Highly diversified shrew hepatitis B viruses corroborate ancient origins and divergent infection patterns of mammalian hepadnaviruses.

Authors:  Andrea Rasche; Felix Lehmann; Alexander König; Nora Goldmann; Victor M Corman; Andres Moreira-Soto; Andreas Geipel; Debby van Riel; Yulia A Vakulenko; Anna-Lena Sander; Hauke Niekamp; Ramona Kepper; Mathias Schlegel; Chantal Akoua-Koffi; Breno F C D Souza; Foday Sahr; Ayodeji Olayemi; Vanessa Schulze; Rasa Petraityte-Burneikiene; Andris Kazaks; Kira A A T Lowjaga; Joachim Geyer; Thijs Kuiken; Christian Drosten; Alexander N Lukashev; Elisabeth Fichet-Calvet; Rainer G Ulrich; Dieter Glebe; Jan Felix Drexler
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

10.  Offspring's Tolerance of Mother Goes Viral.

Authors:  Jeremy M Kinder; Tony T Jiang; Sing Sing Way
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.